07-20-2016, 09:46 AM
I added Abbott Labs (ABT) to my portfolio at $42.75.
Abbott had a nice earnings report this morning, beating both the top and bottom line and also has the upcoming St. Jude Medical (STJ) acquisition that should diversify and expand its offerings and help contribute to future growth. Dividend growth may slow for a year or so as it digests those costs, but in the long run I think Abbott will be a great company to partner with in my portfolio.
Abbott had a nice earnings report this morning, beating both the top and bottom line and also has the upcoming St. Jude Medical (STJ) acquisition that should diversify and expand its offerings and help contribute to future growth. Dividend growth may slow for a year or so as it digests those costs, but in the long run I think Abbott will be a great company to partner with in my portfolio.